Direct To Consumer Genetics Testing Market
Direct-to-Consumer Genetics Testing Market Forecasts to 2028 - Global Analysis By Test Type (Ancestry & Relationship Testing, Carrier Testing, Diabetes Testing and Other Test Types), Services (Diagnostic Screening, New-born Screening, Pre-Implantation Diagnosis and Prenatal), Sample (Saliva, Blood and Urine), Technology (Single Nucleotide Polymorphism (SNP) Chips, Targeted Analysis, Whole Genome Sequencing (WGS) and Other Technologies), End User and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2022) |
US $1.48 BN |
|
Projected Year Value (2028) |
US $3.49 BN |
|
CAGR (2022 - 2028) |
15.3% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Direct-to-Consumer Genetic Testing Market is accounted for $1.48 billion in 2022 and is expected to reach $3.49 billion by 2028 growing at a CAGR of 15.3% during the forecast period. Laboratory tests that can be ordered directly by consumers from their healthcare providers are known as direct-to-consumer tests. After a laboratory has processed the consumer sample, the results are forwarded directly to the customer.
According to MIT Technology Review, the cumulative number of genetic tests conducted in 2019 will exceed 26 million, increasing the demand for automated DNA extraction in the coming years and propelling the market growth.
Market Dynamics:
Driver:
Easy accessibility and rising chronic diseases
In order to get a trained medical professional's interpretation of the results of a genetic test, patients or healthy individuals must go see that professional. These professionals might be doctors, nurses, or counselors. Since the advent of direct-to-consumer (DTC) genetic testing devices, this procedure has either become unnecessary or voluntary. In addition to making such tests more accessible to potential patients, this has significantly reduced the cost of testing. The rise in chronic diseases like cancer, Alzheimer's, and Parkinson's, as well as rising health awareness, particularly in developed nations like the U.S., Canada, and the U.K., are two major factors driving market expansion.
Restraint:
Expensive DTC kits could impede consumer demand
The direct-to-consumer genetic testing market may be hampered by the high costs associated with DTC genetic testing services. In order to introduce high-end DTC tests, many manufacturers are concentrating on product innovations and integrating next-generation technologies, which raises the price of the product. For instance, the price of DTC genetic tests can range from $100 to $3,000, depending on the complexity of the test and the severity of the disease. Because of affordability issues, the demand for genetic services in developing and underdeveloped areas may decline.
Opportunity:
Adoption of genomic medicine in developing countries
Uneven distribution of diagnostic laboratories and insufficient funding are issues in developing countries. Accessibility could be greatly improved by using tests that can be administered without laboratory assistance. The lack of durable and affordable test portfolios, as well as their decreased performance as a result of environmental difficulties like high temperatures and dust, are the main causes of the shortage. However, the majority of the key players in the sector believe that these emerging regions are largely untapped, which makes them perfect for business expansion and producing sizable expansion opportunities in the market.
Threat:
Friction between manufacturers and regulatory agencies
Manufacturers and regulatory agencies have shown very little cooperation in the market for direct-to-consumer genetic testing devices. For instance, 23andMe was founded in 2006, the business began selling its direct-to-consumer (DTC) genetic testing products in 2007, and Time magazine even named the company's product "Invention of the Year" in 2008. However, because 23andMe lacked the necessary legal and regulatory approval, the FDA ordered the company to stop marketing its personal genome service (PGS) in 2013. The business vehemently denied the accusation and continued to market its goods until 2015. The business received the FDA's initial approval for genetic tests for 10 diseases in 2017. Market growth is constrained by the friction between manufacturers and regulatory agencies.
Covid-19 Impact
The COVID-19 pandemic boosted telehealth and telemedicine trends, which in turn had a positive impact on the DTC genetic testing market. Patients became more inclined to use online consultation services as a result of the radical transformation of traditional healthcare operations. DTC genetic tests became more popular, enabling patients to understand their genetic profiles without requiring the assistance of a doctor. Patients also adopted digital health alternatives to meet their medical and therapeutic needs as a result of the introduction of strict lockdown restrictions and social distancing norms deployed to stop the spread of the virus. The industry outlook was also bolstered by the rising popularity of e-pharmacies and online drug stores during this COVID-19 pandemic period.
The predictive testing segment is expected to be the largest during the forecast period
Predictive testing dominated the market in 2022 with a 38.0% revenue share and is anticipated to witness the largest market share during the forecast period. Utilizing genomic data to estimate a person's risk of contracting a specific disease or condition is known as predictive genetic testing. Growing demand for personalized medicine and an increase in the frequency of genetic disorders are factors in the segment's expansion. Additionally, it is anticipated that a rising number of product launches will provide a favorable environment for segment growth.
The targeted analysis segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the targeted analysis segment is anticipated to experience profitable growth. Utilizing methods like polymerase chain reaction (PCR), sequencing, or genotyping, targeted analysis examines particular genetic markers. This makes it possible to find genomic variations that could raise someone's risk of getting certain diseases, like cancer, cardiovascular disease, or inherited genomic disorders. This benefit will likely cause the segment to expand over the course of the prediction period.
Region with largest share:
In 2022, North America held the largest revenue share (60.1%) in the DTC genetic testing market and is expected to dominate throughout the prediction timeline. The dominance is attributed to a substantial change in consumers' attitudes toward genomic testing. The relatively well-developed healthcare system in North America offers a solid foundation for the expansion of genomic examination services, which further accelerates market growth in the region. Additionally, the increase in spending will further fuel market expansion in this region.
Region with highest CAGR:
During the forecast period, Europe is anticipated to have the highest growth rate. The increased focus on early disease detection and prevention, as well as the increased use of genomic examination, among other things, will be the main factors driving market growth in this region. For instance, in order to help Member States address disparities, improve HPV infection screening and vaccination, and support cancer survivors, the European Commission unveiled four new European Union Cancer Plan initiatives in February 2022. Increased vaccination rates are being actively pursued across the continent by several European countries, which is further propelling market expansion.
Key players in the market
Some of the key players profiled in the Direct-to-Consumer Genetic Testing Market include 23andMe, Inc., 24 Genetics, Ancestry, Color Genomics, Inc., Counsyl/Myriad Genetics, Inc. Direct Laboratory Services, LLC, DNA Forensics Laboratory Pvt. Ltd., EasyDNA, Family Tree DNA, Full Genomes Corporation, Inc., Gene by Gene, Ltd., Genesis Healthcare Co., Helix OpCo LLC, Identigene, Interleukin Genetics/orig3n, Karmagenes SA, Laboratory Corporation of America® Holdings, Living DNA Ltd., Mapmygenome, MyHeritage Ltd, Myriad Genetics Inc., OmeCare, Pathway genomics, Positive Bioscience, Inc., Prenetics Limited, Quest Diagnostics, Inc., Request A Test, Ltd., Sonora Quest Laboratories LLC, The SkinDNA Company Pty Ltd, Veritas Genetics and Xcode Life Science.
Key Developments:
In July 2022, Genetic Technologies Limited (ASX: GTG) is pleased to reveal that it has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA.
In July 2022, 1health.io Inc., an industry-leading software company that enables diagnostic laboratories to expand their testing in the clinical and direct-to-consumer markets quickly and securely, collaborated with Apollo Health Group to bring Apollo's specialized high-performing NGS tests, like pharmacogenetics screenings (PGx) and hereditary cancer genetic screenings (CGx), to the broader clinical market.
Test Types Covered:
• Ancestry & Relationship Testing
• Carrier Testing
• Diabetes Testing
• Genetic Health Risk (GHR) Testing
• Nutrigenomic Testing
• Pharmacogenetics testing
• Predictive Testing
• Routine Clinical Testing
• Skincare Testing
• Other Test Types
Services Covered:
• Diagnostic Screening
• New-born Screening
• Pre-Implantation Diagnosis
• Prenatal
Samples Covered:
• Saliva
• Blood
• Urine
Technologies Covered:
• Single Nucleotide Polymorphism (SNP) Chips
• Targeted Analysis
• Whole Genome Sequencing (WGS)
• Other Technologies
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Direct-to-Consumer Genetics Testing Market, By Test Type
5.1 Introduction
5.2 Ancestry & Relationship Testing
5.3 Carrier Testing
5.4 Diabetes Testing
5.5 Genetic Health Risk (GHR) Testing
5.6 Nutrigenomic Testing
5.7 Pharmacogenetics testing
5.8 Predictive Testing
5.9 Routine Clinical Testing
5.10 Skincare Testing
5.11 Other Test Types
6 Global Direct-to-Consumer Genetics Testing Market, By Service
6.1 Introduction
6.2 Diagnostic Screening
6.3 New-born Screening
6.4 Pre-Implantation Diagnosis
6.5 Prenatal
7 Global Direct-to-Consumer Genetics Testing Market, By Sample
7.1 Introduction
7.2 Saliva
7.3 Blood
7.4 Urine
8 Global Direct-to-Consumer Genetics Testing Market, By Technology
8.1 Introduction
8.2 Single Nucleotide Polymorphism (SNP) Chips
8.3 Targeted Analysis
8.4 Whole Genome Sequencing (WGS)
8.5 Other Technologies
9 Global Direct-to-Consumer Genetics Testing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 23andMe, Inc.
11.2 24 Genetics
11.3 Ancestry
11.4 Color Genomics, Inc.
11.5 Counsyl/Myriad Genetics, Inc.
11.6 Direct Laboratory Services, LLC
11.7 DNA Forensics Laboratory Pvt. Ltd.
11.8 EasyDNA
11.9 Family Tree DNA
11.10 Full Genomes Corporation, Inc.
11.11 Gene by Gene, Ltd.
11.12 Genesis Healthcare Co.
11.13 Helix OpCo LLC
11.14 Identigene
11.15 Interleukin Genetics/orig3n
11.16 Karmagenes SA
11.17 Laboratory Corporation of America® Holdings
11.18 Living DNA Ltd.
11.19 Mapmygenome
11.20 MyHeritage Ltd
11.21 Myriad Genetics Inc.
11.22 OmeCare
11.23 Pathway genomics
11.24 Positive Bioscience, Inc.
11.25 Prenetics Limited
11.26 Quest Diagnostics, Inc.
11.27 Request A Test, Ltd.
11.28 Sonora Quest Laboratories LLC
11.29 The SkinDNA Company Pty Ltd
11.30 Veritas Genetics
11.31 Xcode Life Sciences
List of Tables
1 Global Direct-to-Consumer Genetics Testing Market Outlook, By Region (2020-2028) ($MN)
2 Global Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
3 Global Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
4 Global Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
5 Global Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
6 Global Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
7 Global Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
8 Global Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
9 Global Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
10 Global Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
11 Global Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
12 Global Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
13 Global Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
14 Global Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
15 Global Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
16 Global Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
17 Global Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
18 Global Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
19 Global Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
20 Global Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
21 Global Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
22 Global Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
23 Global Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
24 Global Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
25 Global Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
26 Global Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
27 North America Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
28 North America Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
29 North America Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
30 North America Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
31 North America Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
32 North America Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
33 North America Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
34 North America Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
35 North America Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
36 North America Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
37 North America Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
38 North America Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
39 North America Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
40 North America Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
41 North America Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
42 North America Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
43 North America Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
44 North America Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
45 North America Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
46 North America Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
47 North America Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
48 North America Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
49 North America Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
50 North America Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
51 North America Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
52 North America Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
53 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
54 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
55 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
56 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
57 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
58 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
59 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
60 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
61 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
62 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
63 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
64 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
65 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
66 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
67 Europe Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
68 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
69 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
70 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
71 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
72 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
73 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
74 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
75 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
76 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
77 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
78 Europe Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
79 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
80 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
81 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
82 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
83 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
84 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
85 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
86 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
87 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
88 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
89 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
90 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
91 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
92 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
93 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
94 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
95 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
96 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
97 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
98 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
99 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
100 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
101 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
102 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
103 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
104 Asia Pacific Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
105 South America Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
106 South America Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
107 South America Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
108 South America Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
109 South America Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
110 South America Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
111 South America Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
112 South America Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
113 South America Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
114 South America Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
115 South America Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
116 South America Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
117 South America Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
118 South America Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
119 South America Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
120 South America Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
121 South America Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
122 South America Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
123 South America Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
124 South America Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
125 South America Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
126 South America Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
127 South America Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
128 South America Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
129 South America Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
130 South America Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
131 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Country (2020-2028) ($MN)
132 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Test Type (2020-2028) ($MN)
133 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Ancestry & Relationship Testing (2020-2028) ($MN)
134 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Carrier Testing (2020-2028) ($MN)
135 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Diabetes Testing (2020-2028) ($MN)
136 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Genetic Health Risk (GHR) Testing (2020-2028) ($MN)
137 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Nutrigenomic Testing (2020-2028) ($MN)
138 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Pharmacogenetics testing (2020-2028) ($MN)
139 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Predictive Testing (2020-2028) ($MN)
140 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Routine Clinical Testing (2020-2028) ($MN)
141 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Skincare Testing (2020-2028) ($MN)
142 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Other Test Types (2020-2028) ($MN)
143 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Service (2020-2028) ($MN)
144 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Diagnostic Screening (2020-2028) ($MN)
145 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By New-born Screening (2020-2028) ($MN)
146 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Pre-Implantation Diagnosis (2020-2028) ($MN)
147 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Prenatal (2020-2028) ($MN)
148 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Sample (2020-2028) ($MN)
149 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Saliva (2020-2028) ($MN)
150 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Blood (2020-2028) ($MN)
151 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Urine (2020-2028) ($MN)
152 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Technology (2020-2028) ($MN)
153 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Single Nucleotide Polymorphism (SNP) Chips (2020-2028) ($MN)
154 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Targeted Analysis (2020-2028) ($MN)
155 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Whole Genome Sequencing (WGS) (2020-2028) ($MN)
156 Middle East & Africa Direct-to-Consumer Genetics Testing Market Outlook, By Other Technologies (2020-2028) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
